Skip to content

Clinical trials

Observational Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Observational Country / region: Canada Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20042
20052
20062
20072
20086
20093
20103
20113
20126
20135
20147
20155
20169
20173
20184
20195
20208
20212
20224
20233
20244
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting26
Active, not recruiting10
Unknown status10
Terminated4
Withdrawn3
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto20
Exact Sciences Corporation5
AbbVie4
Children's Oncology Group4
Ottawa Hospital Research Institute4
Sunnybrook Health Sciences Centre4
The Hospital for Sick Children3
AO Innovation Translation Center2
British Columbia Cancer Agency2
Centre hospitalier de l'Université de Montréal (CHUM)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms96
Breast Neoplasms8
Colorectal Neoplasms8
Prostatic Neoplasms7
Digestive System Diseases6
Gastrointestinal Diseases6
Neoplasm Metastasis6
Colonic Diseases5
Digestive System Neoplasms5
Gastrointestinal Neoplasms5

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.